Ruth Bell

731 total citations
11 papers, 569 citations indexed

About

Ruth Bell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ruth Bell has authored 11 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Ruth Bell's work include HER2/EGFR in Cancer Research (3 papers), Air Quality and Health Impacts (2 papers) and Advanced Breast Cancer Therapies (2 papers). Ruth Bell is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Air Quality and Health Impacts (2 papers) and Advanced Breast Cancer Therapies (2 papers). Ruth Bell collaborates with scholars based in United Kingdom, United States and Australia. Ruth Bell's co-authors include Svetlana V. Glinianaia, Judith Rankin, Denise Howel, Tanja Pless‐Mulloli, T. Sheldon, Mark Petticrew, Jame Abraham, Khalid Jazieh, Roger Burkinshaw and David Cameron and has published in prestigious journals such as Cancer Research, Environmental Health Perspectives and European Journal of Cancer.

In The Last Decade

Ruth Bell

10 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Bell United Kingdom 5 354 189 114 54 47 11 569
Xiaoli Sun China 17 406 1.1× 156 0.8× 72 0.6× 15 0.3× 27 0.6× 40 864
Bi‐Hua Cheng Taiwan 17 193 0.5× 60 0.3× 33 0.3× 45 0.8× 92 2.0× 36 685
Anna Maria Ingelido Italy 17 677 1.9× 52 0.3× 232 2.0× 52 1.0× 36 0.8× 38 1.0k
Annalisa Abballe Italy 16 571 1.6× 40 0.2× 142 1.2× 30 0.6× 22 0.5× 30 847
Wenzhen Ge United States 16 361 1.0× 87 0.5× 6 0.1× 47 0.9× 79 1.7× 37 694
Ambarina S. Faiz United States 12 139 0.4× 51 0.3× 95 0.8× 9 0.2× 18 0.4× 21 531
Zhijiang Liang China 14 273 0.8× 80 0.4× 16 0.1× 24 0.4× 5 0.1× 27 554
Yun Chul Hong South Korea 12 218 0.6× 53 0.3× 7 0.1× 22 0.4× 57 1.2× 58 656
Amanda E. Janitz United States 14 114 0.3× 20 0.1× 69 0.6× 12 0.2× 106 2.3× 71 494
Julie Carré France 4 225 0.6× 58 0.3× 70 0.6× 9 0.2× 7 0.1× 8 348

Countries citing papers authored by Ruth Bell

Since Specialization
Citations

This map shows the geographic impact of Ruth Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Bell more than expected).

Fields of papers citing papers by Ruth Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Bell. The network helps show where Ruth Bell may publish in the future.

Co-authorship network of co-authors of Ruth Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Bell. A scholar is included among the top collaborators of Ruth Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Bell. Ruth Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Jazieh, Khalid, et al.. (2020). Novel targeted therapies for metastatic breast cancer. Annals of Translational Medicine. 8(14). 907–907. 13 indexed citations
3.
Regan, MM, U. Dafni, Dimitris Karlis, et al.. (2012). Abstract P5-18-02: Selective Crossover in Randomized Trials of Adjuvant Trastuzumab for Breast Cancer: Coping with Success. Cancer Research. 72(24_Supplement). P5–18.
4.
Coleman, RE, W. Gregory, Ruth Bell, et al.. (2011). 5019 POSTER DISCUSSION Discordant Treatment Effects According to Menopausal Status Following Adjuvant Zoledronic Acid in Stage ll/lll Breast Cancer -The AZURE Trial (BIG 01/04). European Journal of Cancer. 47. S336–S336. 2 indexed citations
5.
Muehlbauer, Susanne, Cédric Révil, B Leyland-Jones, et al.. (2009). Pooled cardiac safety analysis of patients with HER2-positive metastatic breast cancer receiving trastuzumab.. Cancer Research. 69(2_Supplement). 6136–6136. 2 indexed citations
6.
Burkinshaw, Roger, H. Thorpe, S. Pollard, et al.. (2006). The AZURE trial – does adjuvant zoledronic acid reduce recurrence in patients with high-risk localised breast cancer?. Bone. 38(3). 70–71. 4 indexed citations
7.
Glinianaia, Svetlana V., Judith Rankin, Ruth Bell, Tanja Pless‐Mulloli, & Denise Howel. (2004). Particulate Air Pollution and Fetal Health. Epidemiology. 15(1). 36–45. 311 indexed citations
8.
Glinianaia, Svetlana V., Judith Rankin, Ruth Bell, Tanja Pless‐Mulloli, & Denise Howel. (2004). Does Particulate Air Pollution Contribute to Infant Death? A Systematic Review. Environmental Health Perspectives. 112(14). 1365–1370. 87 indexed citations
9.
Bell, Ruth. (1999). Screening for ovarian cancer: is it worth the risk?. PubMed. 95(3). 52–3. 1 indexed citations
10.
Bell, Ruth, et al.. (1998). Screening for ovarian cancer: a systematic review.. PubMed. 2(2). i–iv, 1. 43 indexed citations
11.
Bell, Ruth, Mark Petticrew, & T. Sheldon. (1998). The performance of screening tests for ovarian cancer: results of a systematic review. BJOG An International Journal of Obstetrics & Gynaecology. 105(11). 1136–1147. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026